[Innovative MRI techniques in Parkinson's disease].
Brain imaging enables the investigation of brain morphology and function in patients with Parkinson's disease (PD). Innovative magnetic resonance imaging (MRI) techniques have recently been established as a new research tool in PD. They are based on the investigation of neuronal tissue properties (MR relaxometry, SWI, DWI, DTI, VBM) and of cerebral perfusion and neuronal activity (ASL, fcMRI). Besides a better understanding of the pathophysiology of PD, these innovative MR techniques might be suitable for measuring progression of PD and the effect of therapeutic interventions on brain functioning. In the clinical setting, they could help to advance the differential diagnosis of parkinsonian disorders.
Baudrexel
S
S
Klinik für Neurologie, Zentrum der Neurologie und Neurochirurgie,Klinikum der Goethe-Universität Frankfurt am Main, Schleusenweg 2-16, 60528, Frankfurt am Main, Deutschland. Simon.Baudrexel@kgu.de
Klein
J C
JC
Deichmann
R
R
Hilker
R
R
D001921:Brain / Q000098:blood supply / Q000473:pathology* / Q000503:physiopathology; D001931:Brain Mapping; D003287:Contrast Media; D038524:Diffusion Magnetic Resonance Imaging / Q000379:methods; D018450:Disease Progression; D004292:Dominance, Cerebral / Q000502:physiology; D006801:Humans; D007089:Image Enhancement / Q000379:methods*; D007091:Image Processing, Computer-Assisted / Q000379:methods*; D008279:Magnetic Resonance Imaging / Q000379:methods*; D009415:Nerve Net / Q000473:pathology / Q000503:physiopathology; D010101:Oxygen Consumption / Q000502:physiology; D010300:Parkinson Disease / Q000175:diagnosis* / Q000473:pathology / Q000503:physiopathology; D012039:Regional Blood Flow / Q000502:physiology; D012680:Sensitivity and Specificity
D003287:Contrast Media
Brain. 2004 Apr;127(Pt 4):791-800
14749292
Neurosci Lett. 2009 Aug 21;460(1):6-10
19463891
Brain. 1991 Aug;114 ( Pt 4):1953-75
1832073
Brain Res. 2010 May 12;1330:124-30
20303339
Neurobiol Aging. 2003 Mar-Apr;24(2):197-211
12498954
Neurology. 2009 Apr 21;72(16):1378-84
19129507
Proc Natl Acad Sci U S A. 1992 Jan 1;89(1):212-6
1729691
Magn Reson Med. 1994 Sep;32(3):335-41
7984066
Eur J Neurol. 2010 Feb;17(2):314-20
19912319
J Cereb Blood Flow Metab. 2007 Mar;27(3):597-605
16804550
J Neurol Neurosurg Psychiatry. 2004 Mar;75(3):481-4
14966170
AJNR Am J Neuroradiol. 2009 Feb;30(2):232-52
19131406
Curr Opin Neurol. 2009 Aug;22(4):348-55
19491678
Mov Disord. 2009;24 Suppl 2:S711-20
19877241
Neurology. 2008 Apr 15;70(16 Pt 2):1411-7
18172063
Magn Reson Med. 2009 Jan;61(1):125-35
19097220
J Cereb Blood Flow Metab. 2010 Mar;30(3):505-9
20051975
PLoS One. 2009 Dec 10;4(12):e8247
20011063
Nat Rev Neurosci. 2003 Jun;4(6):469-80
12778119
BMC Neurosci. 2009 Nov 23;10:137
19930640
Biophys J. 1994 Jan;66(1):259-67
8130344
Nat Rev Neurol. 2010 Jan;6(1):15-28
20057496
Cereb Cortex. 2010 May;20(5):1175-86
19710357
Neuroimage. 2010 Jun;51(2):512-20
20211271
Brain. 1991 Oct;114 ( Pt 5):2283-301
1933245
Mov Disord. 2009;24 Suppl 2:S691-8
19877198
Magn Reson Med. 2009 Jul;62(1):263-8
19353655
Brain. 2009 Dec;132(Pt 12):3285-97
19952056
Magn Reson Med. 2003 Nov;50(5):1077-88
14587019
Neurochem Res. 2007 Oct;32(10):1646-54
17468954
Magn Reson Med. 1995 Oct;34(4):537-41
8524021
Mov Disord. 2003 Apr;18(4):357-63
12671940
AJNR Am J Neuroradiol. 2009 Jan;30(1):19-30
19039041
Neurology. 2005 Jan 25;64(2):224-9
15668417
Neuroimage. 2009 Aug 15;47(2):435-41
19447183
Lancet. 2009 Jun 13;373(9680):2055-66
19524782
Brain. 2007 Jul;130(Pt 7):1834-46
17470495